Isolated liver perfusion for non-resectable liver tumours: a review
- 1 December 2002
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 28 (8) , 875-890
- https://doi.org/10.1053/ejso.2002.1328
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999
- Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalanEuropean Journal of Surgical Oncology, 1999
- Side effects of cancer treatment with recombinant human tumour necrosis factor alpha: a new challenge for the intensive care unitClinical Intensive Care, 1997
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Isolated Liver Perfusion with Mitomycin C in the Treatment of Colorectal Cancer Metastases Confined to the LiverJapanese Journal of Clinical Oncology, 1996
- Isolated hyperthermic liver perfusion with chemotherapy for liver malignancySurgical Oncology, 1994
- Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival updateCancer, 1994
- Regional chemotherapy of colorectal cancer metastatic to the liverCancer, 1984
- Hyperthermia and CancerRadiation Research, 1983
- Thermal sensitivity and resistance of insulin-receptor bindingBiochimica et Biophysica Acta (BBA) - General Subjects, 1983